Παρασκευή 2 Σεπτεμβρίου 2016

Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan

Summary

Germline PMS2 gene mutations were detected by RT-PCR/direct sequencing of total RNA extracted from puromycin-treated peripheral blood lymphocytes (PBL) and multiplex ligation-dependent probe amplification (MLPA) analyses of Japanese patients with colorectal cancer (CRC) fulfilling either the revised Bethesda guidelines or an age at disease onset of younger than 70 years, and screened by mismatch repair protein immunohistochemistry of formalin-fixed paraffin embedded sections. Of the 501 subjects examined, 7 (1.40%) showed the down-regulated expression of the PMS2 protein alone and were referred to the genetic counseling clinic. Germline PMS2 mutations were detected in 6 (85.7%), including 3 nonsense and 1 frameshift mutations by RT-PCR/direct sequencing and 2 genomic deletions by MLPA. No mutations were identified in the other MMR genes, i.e. MSH2, MLH1, and MSH6. The prevalence of the down-regulated expression of the PMS2 protein alone was 1.40% among the subjects examined and IHC results predicted the presence of PMS2 germline mutations. RT-PCR from puromycin-treated PBL and MLPA may be employed as the first screening step to detect PMS2 mutations without pseudogene interference, followed by the long-range PCR/nested PCR validation using genomic DNA.

This article is protected by copyright. All rights reserved.



from Cancer via ola Kala on Inoreader http://ift.tt/2bImtvb
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου